MEI Pharma Litecoin treasury investment

Key Points:* MEI Pharma adopts Litecoin with $100M fund; GSR advises.

• Charlie Lee joins the board amid successful placement.
• Market shows strong response; MEIP stock increases 85%. Litecoin (LTC) backs significant financial maneuvers accommodating the evolving landscape. According to CoinMarketCap, Litecoin’s current price is $107.66, boasting a market cap of $8.19 billion. Over the past 24 hours, trading volume increased 77.10%, standing at $1.71 billion. Price movements reflect robust gains, climbing 41.64% in the last 90 days alone.

Coincu’s research highlights that Litecoin’s adoption by MEI Pharma could influence broader corporate strategies and ignite discussions about using cryptocurrencies as treasury assets. The decision reflects potential financial shifts, with possible long-term effects on Litecoin’s adoption and valuation in mainstream finance.

Litecoin Surges as MEI Pharma Follows Bitcoin’s Treasury Trend

MEI Pharma has launched a significant financial move by establishing a $100 million Litecoin fund. GSR’s role as strategic advisor marks another notable step. This initiative involves MEI Pharma acquiring Litecoin as their primary treasury asset. Charlie Lee joining MEI Pharma’s board represents a strategic leadership enhancement.

The treasury decision by MEI Pharma affects LTC directly, with no current evidence of other major cryptocurrencies like BTC or ETH being influenced. The company’s actions follow a similar strategy to MicroStrategy’s Bitcoin move and can potentially set a new trend. Investor enthusiasm is palpable, as reflected in the strong premarket rise in MEI Pharma’s stock. GSR’s participation signifies a robust endorsement, potentially boosting confidence in future corporate adoption of Litecoin.

“As part of the deal, Litecoin creator Charlie Lee will join MEI’s board of directors upon closing of the private placement.” — Charlie Lee, Founder of Litecoin

Market Data and Future Implications

Did you know? In 2020, MicroStrategy’s adoption of Bitcoin as a primary treasury asset inspired similar integrations. MEI Pharma’s Litecoin investment could ignite another wave of corporate cryptocurrency treasury strategies.

According to CoinMarketCap, Litecoin’s current price is $107.66, boasting a market cap of $8.19 billion. Over the past 24 hours, trading volume increased 77.10%, standing at $1.71 billion. Price movements reflect robust gains, climbing 41.64% in the last 90 days alone.

Litecoin(LTC), daily chart, screenshot on CoinMarketCap at 13:13 UTC on July 18, 2025. Source: CoinMarketCap Coincu’s research highlights that Litecoin’s adoption by MEI Pharma could influence broader corporate strategies and ignite discussions about using cryptocurrencies as treasury assets. The decision reflects potential financial shifts, with possible long-term effects on Litecoin’s adoption and valuation in mainstream finance.

| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |